News
BIOL
0.1898
-0.68%
-0.0013
Weekly Report: what happened at BIOL last week (0318-0322)?
Weekly Report · 4d ago
Biolase’s Strong Q4 Performance and Positive 2024 Outlook Affirm Buy Rating
TipRanks · 6d ago
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Cutera, Inc. Fell sharply on Friday after the company reported worse-than-expected fourth quarter adjusted EPS results. Murano Global Investments PLC shares jumped 147.5% to $23.94 after falling 46% on Thursday. Other stocks moving in today's mid-day session include Nova LifeStyle, Inc., Worthington Steel and Foot Locker.
Benzinga · 6d ago
Biolase Is Maintained at Speculative Buy by Benchmark
Dow Jones · 6d ago
Biolase Price Target Cut to $0.40/Share From $2.50 by Benchmark
Dow Jones · 6d ago
Benchmark Maintains Speculative Buy on Biolase, Lowers Price Target to $0.4
Benzinga · 6d ago
12 Health Care Stocks Moving In Friday's Intraday Session
IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 91.5% to $2.47 during Friday's regular session. The company's Q4 earnings report came out yesterday. Virios Therapeutics shares increased by 37.98% and Ontrak shares rose by 35.03% in the same session.
Benzinga · 6d ago
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
U.S. Stocks traded lower on Friday, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04%. Shares of Nike Inc fell more than 8% after the company reported results for its third quarter. Communication services shares jumped by 0.7% on Friday. Asian markets closed mixed in trading.
Benzinga · 6d ago
Biolase Shares Jump 27% After Upbeat 2024 Revenue Guidance
Biolase's shares were up 27% to 19.1 cents in recent trading. The stock has fallen almost 83% year to date. The dental laser technology company said it expects revenue to rise in 2024. The company expects net revenue of $49.2 million in 2023.
Dow Jones · 03/22 15:33
Why BIOLASE Shares Are Surging Friday
BIOLASE, Inc. Reported better-than-expected fourth-quarter FY23 EPS results. Revenue of $13.49 million missed the consensus of $14.55 million. The company expects dental lasers to continue to be a key growth driver for the dental industry.
Benzinga · 03/22 15:13
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
The Dow traded down 0.06% to 39,758.88 and the NASDAQ fell 0.10% on Friday. FedEx Corporation reported better-than-expected earnings for its third quarter. Utilities shares jumped by 0.5% in trading on Friday and consumer discretionary shares fell by 1%. Asian markets closed mixed on Friday; European shares were mostly higher.
Benzinga · 03/22 13:45
BUZZ-U.S. STOCKS ON THE MOVE-Hookipa Pharma, Foot Locker, Baidu
S&P 500 and the Nasdaq were set to open lower on Friday after strong gains in the previous session. Investors cheered the Federal Reserve sticking to its rate-easing stance. Hookipa Pharma, Foot Locker, Baidu are among the top stocks on the U.S. Market.
Reuters · 03/22 13:14
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Biolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. Eton Pharmaceuticals shares rose 15.46% during the day. Outlook Therapeutics and Nutriband also moved upwards. SINTX Techs shares declined by 34.0% in the pre- market.
Benzinga · 03/22 13:06
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter. FedEx reported quarterly earnings of $3.86 per share and authorized a new $5 billion share repurchase program. Nike, Inc. Shares tumbled 6.3% on Thursday after posting upbeat earnings and sales results.
Benzinga · 03/22 12:10
BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023
Biolase reported results for the fourth quarter of 2023. Biolase reported earnings per share of -$1.76. The company reported revenue of $13.49 million. This was 0.44% worse than the analyst estimate for revenue of
Investorplace · 03/22 00:53
BIOLASE Inc reports results for the quarter ended in December - Earnings Summary
BIOLASE Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of $1.76 per share. Revenue fell 4% to $13.49 million from a year ago. BIOLASE shares had fallen by 86.7% this quarter.
Reuters · 03/21 23:18
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Biolase (NASDAQ:BIOL) stock rose 20.0% to $0.18 during Thursday's after-market session. The company's market cap increased to $466.4 million. Terns Pharma shares rose 10.14% after their Q4 earnings came out today. Aptevo Therapeutics and Evolus also moved upwards.
Benzinga · 03/21 21:33
Earnings Scheduled For March 21, 2024
Creative Realities is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. Welltower is likely to report earnings for its fourth quarter. Accenture is also projected to report before the bell. Other companies expected to be reporting before the Bell include Shoe Carnival, Y.M.C. And Y.T.
Benzinga · 03/21 10:15
Biolase Q4 2023 Earnings Preview
BIOLASE, Inc. Is scheduled to announce Q4 earnings results on Thursday, March 21st. The consensus EPS Estimate is -$0.90 and the consensus revenue estimate is $13.22M. Over the last 2 years, BIOL has beaten revenue estimates 63% of the time.
Seeking Alpha · 03/20 21:35
More
Webull provides a variety of real-time BIOL stock news. You can receive the latest news about Biolase Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIOL
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.